In 2019, the European Society of Cardiology/European Atherosclerosis Society stated that
apolipoprotein B (apoB) was a more accurate marker of cardiovascular risk than low‐density …

Abstract Purpose of Review Patients with non-alcoholic fatty liver disease (NAFLD), often
considered as the hepatic manifestation of the metabolic syndrome, represent a population …

Triglyceride-rich lipoproteins, remnant-cholesterol, and ath... : Current Opinion in Lipidology
Triglyceride-rich lipoproteins, remnant-cholesterol, and atherosclerotic cardiovascular disease …

Dyslipidemia is a major risk factor for atherosclerotic cardiovascular disease and a healthy
lifestyle is the first line of therapy for treatment. A healthy dietary pattern is a cornerstone for …

Short tandem repeats (STRs) are genomic regions consisting of repeated sequences of 1–6
bp in succession. Single-nucleotide polymorphism (SNP)-based genome-wide association …

Introduction Primary chylomicronemia is characterized by pathological accumulation of
chylomicrons in the plasma causing severe hypertriglyceridemia, typically> 10 mmol/L (> …

Metabolic syndrome (MetS) refers to a cluster of metabolic dysregulations, which include
insulin resistance, obesity, atherogenic dyslipidemia and hypertension. The complex …

Aims/hypothesis This study explored the hypothesis that significant abnormalities in the
metabolism of intestinally derived lipoproteins are present in individuals with type 2 diabetes …

Dyslipidemias have emerged as prevalent disorders among patients, posing significant risks
for the development and progression of cardiovascular diseases. These conditions are …

Metabolic changes in pregnant women begin in the first weeks after conception under the
influence of placental hormones that affect the metabolism of all nutrients. An increased …